LXRX LEXICON PHARMACEUTICALS, INC.
Healthcare · Pharmaceutical Preparations · Market cap: $797.0M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $49.3M | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $72.4M | $0 |
| 2023-Q3 | $24.8K | $0 |
| 2023-Q4 | $1.4M | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $2.7M | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $50.0K | $0 |
Bought$126.0M28 buy days
Sold$00 sell days
Net insider flow+$126.0Mnet buying · 5 years
Latest trade2026-11-06Exton Michael
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-06 | Buy | Exton Michael | CEO | 30,064 | $1.66 | $50.0K | 1 |
| 2026-02-25 | Buy | DEBBANE RAYMOND | Director | 2,000 | $1.49 | $3.0K | 1 |
| 2026-02-23 | Buy | DEBBANE RAYMOND | Director | 100,000 | $1.47 | $147.0K | 1 |
| 2026-02-20 | Buy | DEBBANE RAYMOND | Director | 100,000 | $1.48 | $148.0K | 1 |
| 2026-02-19 | Buy | DEBBANE RAYMOND | Director | 50,000 | $1.44 | $72.0K | 1 |
| 2026-02-18 | Buy | DEBBANE RAYMOND | Director | 133,688 | $1.32 | $176.5K | 1 |
| 2026-02-17 | Buy | DEBBANE RAYMOND | Director | 76,857 | $1.31 | $100.7K | 1 |
| 2026-02-13 | Buy | DEBBANE RAYMOND | Director | 57,952 | $1.31 | $75.9K | 1 |
| 2026-02-02 | Buy | DEBBANE RAYMOND | Director | 1,538,462 | $1.30 | $2.0M | 1 |
| 2023-11-16 | Buy | COATS LONNEL | CEO | 90,000 | $1.05 | $94.5K | 1 |
| 2023-11-13 | Buy | Amouyal Philippe | Director | 200,000 | $1.01 | $202.0K | 1 |
| 2023-11-10 | Buy | COATS LONNEL | CEO | 10,000 | $1.01 | $10.1K | 1 |
| 2023-10-12 | Buy | DEBBANE RAYMOND | Director | 148,820 | $1.03 | $153.3K | 1 |
| 2023-10-11 | Buy | DEBBANE RAYMOND | Director | 342,874 | $1.08 | $370.3K | 1 |
| 2023-10-10 | Buy | DEBBANE RAYMOND | Director | 508,306 | $1.14 | $579.5K | 1 |
| 2023-09-14 | Buy | WADE JEFFREY L | President | 10,000 | $1.38 | $13.8K | 1 |
| 2023-08-04 | Buy | McDermott Wendy | VP | 6,000 | $1.84 | $11.0K | 1 |
| 2023-06-29 | Buy | COATS LONNEL | CEO | 10,000 | $2.16 | $21.6K | 1 |
| 2023-06-26 | Buy | COATS LONNEL | CEO | 10,000 | $2.18 | $21.8K | 1 |
| 2023-06-23 | Buy | COATS LONNEL | CEO | 10,000 | $2.50 | $25.0K | 1 |
| 2023-06-23 | Buy | McDermott Wendy | VP | 10,000 | $2.43 | $24.3K | 1 |
| 2023-06-22 | Buy | COATS LONNEL | CEO | 40,000 | $2.31 | $92.4K | 1 |
| 2023-06-20 | Buy | WADE JEFFREY L | President | 12,000 | $2.34 | $28.1K | 2 |
| 2023-06-05 | Buy | Artal International S.C.A. | Director | 27,775,050 | $2.60 | $72.2M | 1 |
| 2022-08-05 | Buy | Artal International S.C.A. | Director | 2,426,070 | $2.50 | $6.1M | 1 |
| 2022-08-05 | Buy | DEBBANE RAYMOND | Director | 147,390 | $2.50 | $368.5K | 1 |
| 2022-08-01 | Buy | Artal International S.C.A. | Director | 16,173,800 | $2.50 | $40.4M | 1 |
| 2022-08-01 | Buy | DEBBANE RAYMOND | Director | 982,600 | $2.50 | $2.5M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| DEBBANE RAYMOND | Director | $125.4M | $0 | 2026-02-25 |
| COATS LONNEL | CEO | $265.4K | $0 | 2023-11-16 |
| Amouyal Philippe | Director | $202.0K | $0 | 2023-11-13 |
| Exton Michael | CEO | $50.0K | $0 | 2026-11-06 |
| WADE JEFFREY L | President | $41.9K | $0 | 2023-09-14 |
| McDermott Wendy | VP | $35.3K | $0 | 2023-08-04 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2023-09-14 → 2023-11-16 | 4 | $1.4M | 58 | +6.3% (+20.4% raw) | +213.7% (+231.5% raw) | +50.3% (+70.4% raw) | closed |
| 2023-06-05 → 2023-06-29 | 4 | $72.4M | 65 | -26.8% (-18.9% raw) | -53.7% (-56.0% raw) | -59.1% (-47.7% raw) | closed |
| 2019-08-02 → 2019-09-18 | 6 | $1.5M | 66 | +151.1% (+154.3% raw) | +154.7% (+160.7% raw) | +80.4% (+92.1% raw) | closed |
| 2017-11-10 → 2017-11-17 | 3 | $7.5M | 67 | -7.0% (-1.5% raw) | -26.5% (-22.5% raw) | -15.8% (-4.1% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.